Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Leach

Showing results (301-310 of 326) with videos related to

Pageof 33
Sort By:
Nucleic Acids Research|October 5, 2017
p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cellsManikandan Periyasamy, Anup K Singh, Carolina Gemma, et al.
Journal of Experimental Botany|April 22, 2026
A maize GT14 family glycosyltransferase affects cell wall composition and carbohydrate export from source leavesTyler J McCubbin, Rachel A Mertz, R Frank Baker, et al.
British Journal of Cancer|April 19, 2023
The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancerTheodora A Constantin, Anabel Varela-Carver, Kyle K Greenland, et al.
British Journal of Cancer|February 14, 2024
Correction: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancerTheodora A Constantin, Anabel Varela-Carver, Kyle K Greenland, et al.
Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Potent, orally active inhibitors of lipoprotein-associated phospholipase A(2): 1-(biphenylmethylamidoalkyl)-pyrimidonesHelen F Boyd, Stephen C M Fell, Deirdre M B Hickey, et al.
Cell Reports|April 16, 2023
AMPK activation protects against prostate cancer by inducing a catabolic cellular stateLucy Penfold, Angela Woods, Alice E Pollard, et al.
British Journal of Pharmacology|August 20, 2010
GSK1562590, a slowly dissociating urotensin-II receptor antagonist, exhibits prolonged pharmacodynamic activity ex vivoD J Behm, N V Aiyar, A R Olzinski, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
1-(Arylpiperazinylamidoalkyl)-pyrimidones: orally active inhibitors of lipoprotein-associated phospholipase A(2)J C Bloomer, H F Boyd, D M Hickey, et al.
Communications Biology|April 28, 2023
The Newfoundland and Labrador mosaic founder population descends from an Irish and British diaspora from 300 years agoEdmund Gilbert, Heather Zurel, Margaret E MacMillan, et al.
Lancet (London, England)|March 30, 2005
Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trialF T Cutts, S M A Zaman, G Enwere, et al.
Pageof 33

Showing results (301-310 of 326) with videos related to

Sort By:
Pageof 33
Nucleic Acids Research|October 5, 2017
p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cellsManikandan Periyasamy, Anup K Singh, Carolina Gemma, et al.
Journal of Experimental Botany|April 22, 2026
A maize GT14 family glycosyltransferase affects cell wall composition and carbohydrate export from source leavesTyler J McCubbin, Rachel A Mertz, R Frank Baker, et al.
British Journal of Cancer|April 19, 2023
The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancerTheodora A Constantin, Anabel Varela-Carver, Kyle K Greenland, et al.
British Journal of Cancer|February 14, 2024
Correction: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancerTheodora A Constantin, Anabel Varela-Carver, Kyle K Greenland, et al.
Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Potent, orally active inhibitors of lipoprotein-associated phospholipase A(2): 1-(biphenylmethylamidoalkyl)-pyrimidonesHelen F Boyd, Stephen C M Fell, Deirdre M B Hickey, et al.
Cell Reports|April 16, 2023
AMPK activation protects against prostate cancer by inducing a catabolic cellular stateLucy Penfold, Angela Woods, Alice E Pollard, et al.
British Journal of Pharmacology|August 20, 2010
GSK1562590, a slowly dissociating urotensin-II receptor antagonist, exhibits prolonged pharmacodynamic activity ex vivoD J Behm, N V Aiyar, A R Olzinski, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
1-(Arylpiperazinylamidoalkyl)-pyrimidones: orally active inhibitors of lipoprotein-associated phospholipase A(2)J C Bloomer, H F Boyd, D M Hickey, et al.
Communications Biology|April 28, 2023
The Newfoundland and Labrador mosaic founder population descends from an Irish and British diaspora from 300 years agoEdmund Gilbert, Heather Zurel, Margaret E MacMillan, et al.
Lancet (London, England)|March 30, 2005
Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trialF T Cutts, S M A Zaman, G Enwere, et al.
Pageof 33